LISATA

Live / Applied — Statement of use — response to non-final action entered (as of 09 Nov 2026)

What this means for you

Not registered yet, but its 22 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97377210
Mark type
Word mark
Filed
22 Apr 2022
Published for opposition
18 Apr 2023
Attorney of record
Karen Won

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in cancer, tumors; Pharmaceutical preparations for use in treating and managing diseases, disorders, and conditions involving oncology; Therapeutic pharmaceutical preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for altering immunosuppressive tumor microenvironments
  • Class 042 — Scientific and technological services: Research and development in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies and oncology; Providing medical scientific information in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies

Owner

Prosecution history

  • 09 Nov 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 09 Nov 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 09 Nov 2026 — ASSIGNED TO LIE
  • 04 Nov 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 06 Aug 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 06 Aug 2026 — NON-FINAL ACTION E-MAILED
  • 06 Aug 2026 — SU - NON-FINAL ACTION - WRITTEN
  • 29 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
  • 15 Jun 2026 — USE AMENDMENT FILED
  • 15 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
  • 07 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 06 May 2026 — SOU EXTENSION 5 GRANTED
  • 02 Dec 2025 — SOU EXTENSION 5 FILED
  • 06 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 03 Dec 2025 — SOU TEAS EXTENSION RECEIVED

View this trademark record on Rightsy